Wells Fargo’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-79
Closed -$35 7187
2024
Q1
$35 Hold
79
﹤0.01% 6550
2023
Q4
$58 Buy
79
+14
+22% +$10 ﹤0.01% 6458
2023
Q3
$56 Buy
65
+3
+5% +$3 ﹤0.01% 6518
2023
Q2
$116 Hold
62
﹤0.01% 6527
2023
Q1
$229 Sell
62
-199
-76% -$735 ﹤0.01% 6419
2022
Q4
$995 Buy
261
+200
+328% +$762 ﹤0.01% 5865
2022
Q3
$0 Buy
61
+51
+510% ﹤0.01% 7280
2022
Q2
$0 Hold
10
﹤0.01% 7375
2022
Q1
$0 Hold
10
﹤0.01% 7436
2021
Q4
$1K Hold
10
﹤0.01% 6543
2021
Q3
$1K Hold
10
﹤0.01% 6503
2021
Q2
$1K Sell
10
-304
-97% -$30.4K ﹤0.01% 6435
2021
Q1
$46K Sell
314
-1,327
-81% -$194K ﹤0.01% 5501
2020
Q4
$230K Buy
1,641
+133
+9% +$18.6K ﹤0.01% 4885
2020
Q3
$229K Buy
1,508
+256
+20% +$38.9K ﹤0.01% 4737
2020
Q2
$220K Buy
1,252
+1,220
+3,813% +$214K ﹤0.01% 4695
2020
Q1
$4K Buy
+32
New +$4K ﹤0.01% 5597
2019
Q4
Hold
0
6304
2019
Q3
Hold
0
6265
2019
Q2
Hold
0
6254
2019
Q1
Hold
0
6157
2018
Q4
Hold
0
6076
2018
Q3
Hold
0
6099
2018
Q2
Hold
0
6090
2018
Q1
Sell
-2
Closed -$2K 6054
2017
Q4
$2K Hold
2
﹤0.01% 5762
2017
Q3
$1K Hold
2
﹤0.01% 5815
2017
Q2
$1K Buy
+2
New +$1K ﹤0.01% 5749
2017
Q1
Hold
0
6011
2016
Q4
Hold
0
6017
2016
Q3
Hold
0
5992
2016
Q2
Sell
-1
Closed -$1K 6014
2016
Q1
$1K Hold
1
﹤0.01% 5835
2015
Q4
$2K Sell
1
-4
-80% -$8K ﹤0.01% 5726
2015
Q3
$5K Sell
5
-5
-50% -$5K ﹤0.01% 5583
2015
Q2
$10K Buy
10
+5
+100% +$5K ﹤0.01% 5572
2015
Q1
$5K Sell
5
-2
-29% -$2K ﹤0.01% 5590
2014
Q4
$23K Hold
7
﹤0.01% 5100
2014
Q3
$20K Sell
7
-20
-74% -$57.1K ﹤0.01% 5146
2014
Q2
$104K Buy
27
+9
+50% +$34.7K ﹤0.01% 4555
2014
Q1
$96K Buy
18
+17
+1,700% +$90.7K ﹤0.01% 4577
2013
Q4
$3K Hold
1
﹤0.01% 5316
2013
Q3
$3K Hold
1
﹤0.01% 5257
2013
Q2
$3K Buy
+1
New +$3K ﹤0.01% 5185